Combination Therapies Committee

The Combination Therapies Committee oversees the development of guidance publications addressing the opportunities and challenges with combining cancer immunotherapy treatments with other existing or emerging cancer treatment options. The committee provides a summary of the current state of combination immunotherapies, hurdles to clinical trials and approvals when agents are used in combination, and identifies opportunities and recommendations on future combination options in the interest of optimal patient care.

Current Members